SEARCH

SEARCH BY CITATION

References

  • Brewer, C.J., Coates, T.D. & Wood, J.C. (2009) Spleen R2 and R2* in iron-overloaded patients with sickle cell disease and thalassemia major. Journal of Magnetic Resonance Imaging, 29, 357364.
  • Cohen, A.R., Glimm, E. & Porter, J.B. (2008) Effect of transfusional iron intake on response to chelation therapy in beta-thalassemia major. Blood, 111, 583587.
  • Fung, E.B., Harmatz, P.R., Lee, P.D., Milet, M., Bellevue, R., Jeng, M.R., Kalinyak, K.A., Hudes, M., Bhatia, S. & Vichinsky, E.P. (2006) Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. British Journal of Haematology, 135, 574582.
  • Fung, E.B., Harmatz, P., Milet, M., Ballas, S.K., De Castro, L., Hagar, W., Owen, W., Olivieri, N., Smith-Whitley, K., Darbari, D., Wang, W. & Vichinsky, E. (2007) Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: a report from the multi-center study of iron overload. American Journal of Hematology, 84, 255265.
  • Fung, E.B., Harmatz, P.R., Milet, M., Balasa, V., Ballas, S.K., Casella, J.F., Hilliard, L., Kutlar, A., McClain, K.L., Olivieri, N.F., Porter, J.B. & Vichinsky, E.P. (2008) Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions. Transfusion, 48, 19711980.
  • Ghugre, N.R., Enriquez, C.M., Gonzalez, I., Nelson, M.D., Jr., Coates, T.D. & Wood, J.C. (2006a) MRI detects myocardial iron in the human heart. Magnetic Resonance in Medicine, 56. 681686.
  • Ghugre, N.R., Enriquez, C.M., Coates, T.D., Nelson, Jr, M.D. & Wood, J.C. (2006b) Improved R2* measurements in myocardial iron overload. Journal of Magnetic Resonance Imaging, 23, 916.
  • Glickstein, H., El, R.B., Link, G., Breuer, W., Konijn, A.M., Hershko, C., Nick, H. & Cabantchik, Z.I. (2006) Action of chelators in iron-loaded cardiac cells: accessibility to intracellular labile iron and functional consequences. Blood, 108, 31953203.
  • Mazumdar, M., Heeney, M.M., Sox, C.M. & Lieu, T.A. (2007) Preventing stroke among children with sickle cell anemia: an analysis of strategies that involve transcranial Doppler testing and chronic transfusion. Pediatrics, 120, e1107e1116.
  • Noetzli, L.J., Papudesi, J., Coates, T.D. & Wood, J.C. (2009) Pancreatic iron loading predicts cardiac iron loading in thalassemia major. Blood, 114, 40214026.
  • Oudit, G.Y., Sun, H., Trivieri, M.G., Koch, S.E., Dawood, F., Ackerley, C., Yazdanpanah, M., Wilson, G.J., Schwartz, A., Liu, P.P. & Backx, P.H. (2003) L-type Ca(2+) channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nature Medicine, 9, 11871194.
  • Schein, A., Enriquez, C., Coates, T.D. & Wood, J.C. (2008) Magnetic resonance detection of kidney iron deposition in sickle cell disease: a marker of chronic hemolysis. Journal of Magnetic Resonance Imaging, 28, 698704.
  • Vichinsky, E.P. (2001) Current issues with blood transfusions in sickle cell disease. Seminars in Hematology, 38, 1422.
  • Vichinsky, E., Butensky, E., Fung, E., Hudes, M., Theil, E., Ferrell, L., Williams, R., Louie, L., Lee, P.D. & Harmatz, P. (2005) Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia. American Journal of Hematology, 80, 7074.
  • Walter, P.B., Macklin, E.A., Porter, J., Evans, P., Kwiatkowski, J.L., Neufeld, E.J., Coates, T., Giardina, P.J., Vichinsky, E., Olivieri, N., Alberti, D., Holland, J. & Harmatz, P. (2008) Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial. Haematologica, 93, 817825.
  • Ware, R. (2007) Principles and indications of chronic transfusion therapy for children with sickle cell disease. Clinical advances in hematology and oncology, 5, 686688.
  • Wood, J.C., Tyszka, J.M., Ghugre, N., Carson, S., Nelson, M.D. & Coates, T.D. (2004) Myocardial iron loading in transfusion-dependent thalassemia and sickle-cell disease. Blood, 103, 19341936.
  • Wood, J.C., Enriquez, C., Ghugre, N., Tyzka, J.M., Carson, S., Nelson, M.D. & Coates, T.D. (2005a) MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood, 106, 14601465.
  • Wood, J.C., Otto-Duessel, M., Aguilar, M., Nick, H., Nelson, M.D., Coates, T.D., Pollack, H. & Moats, R. (2005b) Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy. Circulation, 112, 535543.